Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy

@article{Uetani2012HalfdoseVO,
  title={Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy},
  author={Ruka Uetani and Yoshikazu Ito and Kazuhiro Oiwa and Kohei Ishikawa and Hiroko Terasaki},
  journal={Eye},
  year={2012},
  volume={26},
  pages={640-649}
}
PurposeTo prospectively compare the effects of half-dose verteporfin (3 mg/m2) photodynamic therapy (1/2 PDT) with those of one-third-dose verteporfin (2 mg/m2) PDT (1/3 PDT) for chronic central serous chorioretinopathy (CSC).MethodsSixteen eyes of 16 consecutive patients with chronic CSC were enrolled and followed up for a 3-month study period. The first 10 patients received 1/2 PDT and the next 6 patients received 1/3 PDT. The resolution rate of subretinal fluid (SRF) was compared between the… CONTINUE READING

Figures, Tables, and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 30 CITATIONS

Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis

  • Progress in Retinal and Eye Research
  • 2015
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Advances in the treatment of central serous chorioretinopathy.

  • Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
  • 2015
VIEW 17 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Evaluation of Choroidal Layer Thickness in Central Serous Chorioretinopathy

  • Journal of ophthalmic & vision research
  • 2019
VIEW 2 EXCERPTS
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 30 REFERENCES